Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Concentration–QTc Modeling to Support Clinical Development of Fezolinetant
Concentration–QTc Modeling to Support Clinical Development of Fezolinetant
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jace C. Nielsen
,
Masako Saito
,
Xuegong Wang
,
Megumi Iwai
,
Graeme L. Fraser
,
Steven Ramael
,
Jiayin Huang
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Clinical Pharmacology in Drug Development
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Description
DOI:
10.1002/cpdd.1613
Similar Items
Pharmacokinetics, Tolerability, and Biomarker Profile of the Neurokinin 3 Receptor Antagonist Fezolinetant in Healthy Japanese Individuals: A 2‐Part, Randomized, Phase 1 Study
by: Akira Koibuchi, et al.
Published: (2025)
Lack of Concentration‐QTc Relationship and Cardiac Risk With Vatiquinone Therapeutic and Supratherapeutic Doses
by: Lucy Lee, et al.
Published: (2024)
Concentration‐QTc Modeling of the DPP‐4 Inhibitor HSK7653 in a First‐in‐Human Study of Chinese Healthy Volunteers
by: Xiaoxu Wang, et al.
Published: (2024)
In Vitro Evaluation of CYP‐Mediated Metabolism of Fezolinetant and Pharmacokinetic Interaction Between Fezolinetant and Fluvoxamine in Healthy Postmenopausal Smokers and Nonsmokers
by: Megumi Iwai, et al.
Published: (2024)
Pharmacokinetics and Safety of Fezolinetant in Women with Hepatic or Renal Impairment
by: Megumi Iwai, et al.
Published: (2025)